Personal Products

Estee Lauder Co. (EL) recently jumped to a new multi-year high after reporting an awesome Q3 earnings surprise of 26% in early November. With consistent earnings over the last four quarters and a bullish next-year estimate, this Zacks #1 rank stock has plenty of upward momentum ahead of the...

Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List - Stocks to Sell Now by 80% annually (+2% versus +10%). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid...

China Sky One Medical, Inc. (Nasdaq: CSKI) today announced that Mr. Hong-yu Pan was appointed by the Company's Board of Directors to serve as the Company's Chief Financial Officer and Treasurer, effective as of November 19, 2010.

Nutraceutical International Corporation (Nasdaq: NUTR) today reported results for the fiscal 2010 fourth quarter. Net sales for the fiscal 2010 fourth quarter were $42.8 million compared to $41.4 million for the same quarter of fiscal 2009. For the fourth quarter of fiscal 2010, net income was $...

Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List - Stocks to Sell Now by 80% annually (+2% versus +10%). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid...

Deutsche Bank has published a research report on Nu Skin Enterprises (NYSE: NUS) after the company hosted an Analyst Day. In the report, Deutsche Bank writes "Fundamentals remain compelling with ageLOC transformation seeing solid repeat purchasers, Vitality trending well and launching in key...

Nu Skin Enterprises Inc (NYSE: NUS) was upgraded by BofA/Merrill from "neutral" to "buy.” NUS' shares closed at $31.31 yesterday. Nu Skin's quarterly earnings surged 37.61% y/y. Goldman Sachs upgrade DuPont (NYSE: DD) from "neutral" to "buy." DD's shares closed at $46.53 yesterday. DuPont's...

Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List - Stocks to Sell Now by 80% annually (+2% versus +10%). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid...

Oppenheimer & Co. is upgrading shares of The Estee Lauder Companies Inc. (NYSE: EL) to Perform from Underperform, and it has a $95 price target on shares. In a note sent to clients, Oppenheimer writes, "We are upgrading the shares of EL to Perform from Underperform, as our cautious thesis...

Oppenheimer upgrades Estee Lauder (NYSE: EL) to Perform from Underperform.

Analysts at Oppenheimer & Co upgrade The Estee Lauder Companies Inc (NYSE: EL) from "underperform" to "perform." EL's shares gained 1.92% to close at $72.34 yesterday. More Analyst Ratings here

Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List - Stocks to Sell Now by 80% annually (+2% versus +10%). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid...

Shares of Medifast, Inc. (NYSE: MED) are lower on the session by 1.65%, trading at $23.20. Overall put volume is now running at 3.58x the daily average, with 39% of all puts traded being purchases on the offer. 1,539 contracts have traded on the session so far. Medifast, Inc. is engaged in the...

Elizabeth Arden, Inc.'s (RDEN) share price has entered into oversold territory with a stochastic value of 13.90. The Zacks Consensus Estimate on the company's earnings for June 2011 increased by 2 cents over the past month to $1.22 per share. Elizabeth Arden, Inc is a Zacks #2 Rank (“Buy”) company...